Semaglutide
* Please be kindly noted that our product can only be used for research to organizations or companies and not intended for individuals.
CAT#
10-101-175
Chemical Structure
CAS No.
910463-68-2
Explanation
Semaglutide is an agonist of glucagon-like peptide-1 (GLP-1) receptor that is developed to treat type 2 diabetes. It reduces blood sugar via increasing the production of insulin. On Oct 18, 2017, Novo Nordisk received positive 16-0 vote from FDA Advisory Committee in favor of approval for Semaglutide.
Synonyms/Alias
UNII-53AXN4NNHX;NNC 0113-0217;53AXN4NNHX
Molecular Formula
C187H291N45O59
M.W/Mr.
4113.641
Technical Data
Related Products
Useful Tools
Publications
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at .
We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry
